Aneurysm is a type of disorder that causes bulge formation in arteries. The disease generally occurs due to damaging of arteries. The bulge formation leads an increased force against an injured wall inside the artery. This further leads to rupturing of the artery and severe bleeding. Aneurysm mostly occurs in aorta that supply oxygen-rich blood from the heart to other parts of the body. There are certain risk factors associated with aneurysm such as high blood pressure, smoking, atherosclerosis, and aging. Bacterial infection and syphilis are also known to cause aortic aneurysm. The University of California, San Francisco is in the process of developing infliximab as an anti-human tumor necrosis factor monoclonal antibody for the treatment of aneurysm. The Rush University is in the process of developing estradiol for the treatment of aneurysm. Some of the universities having the pipeline of aneurysm include Rush University, University of California, San Francisco, and others.
The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.